We are taking a pro-active approach to healthcare, with Scotland’s first private screening service for liver health

About Us

LiverScan aims to identify individuals with potential liver disease and fatty livers using the gold standard examination with a FibroScan device. Every day in the UK, more than 40 people die from liver disease and 25% of the adult population are currently estimated to have non-alcoholic fatty liver disease (NAFLD). Our aim is to be one step ahead and encourage people to take control of their liver health.

The company was formed by a group of friends with medical, health and business angel backgrounds. One of the group came across the FibroScan device following his own MRI examination which was not targeting the liver, but which indicated a potential fatty liver. That diagnosis lead to an examination using the FibroScan device, carried out by a hepatologist. Without that MRI scan identifying an issue, and because most liver disease is asymptomatic, the fatty liver issue would not have been identified, addressed or resolved.

The examination using the FibroScan device, a non-invasive ultrasound procedure, produces 2 results: liver fat (CAP) and liver stiffness (LSM) scores. Fatty liver disease can lead to liver inflammation, scarring and eventually liver cirrhosis or liver cancer. Whilst alcohol can be the cause, in the UK, roughly half of liver disease is classified as NAFLD. It is hugely important that liver disease is caught early, and with simple changes in lifestyle, the damage can often be reversed, partly because of the regenerative nature of the organ itself.

Our group of shareholders all quickly bought into the importance of liver health and the benefits that could result from introducing examinations using the FibroScan device within Scotland on a self-referral basis.

We have also established an advisory board to review our clinical operations, who provide valuable expertise and guidance to optimise our service and ensure patient-centric excellence.

Read our Latest News

LiverScan Group Team

The Team


Ian Gray

Founder & Non-Executive Director
B. Com (Hons) CA


Professor Walter Nimmo

Non-Executive Chairman


Bruce Anderson,

Chief Executive Officer & Executive Director


Claire Hardie

Chief Operating Officer & Executive Director
BSc And MSc in Radiotherapy & Oncology


Chris Ross

Non-Executive Director


LiverScan takes great pride in its approach to managing and conducting its operations. We are deeply committed to upholding the utmost standards in quality and customer engagement, IT security, health and safety, and environmental sustainability. You can download a copy of our certificates below.

Latest News

Take Control of Your Liver Health with FibroScan

Read the article below from our partner CAS Medical  Tireless.…
Liver Info

Embracing the #MagicOfWalking for Liver Health

As the calendar flips to May, it's time to lace up those walking…

Liver Vitality: Excellence in Primary Care

On the 12th of March, LiverScan, hosted a GP Education Event:…
Corporate Booking

Enhancing Corporate Health

In the dynamic landscape of corporate wellness initiatives, companies…

Claire’s Dry January Achievement

In a world where our schedules are filled with professional commitments,…

Double the Detox: Embracing Dry January and Veganuary for a Healthy Liver

As the new year unfolds, many individuals are taking a proactive…
Please enable JavaScript in your browser to complete this form.
Please enable JavaScript in your browser to complete this form.


British Liver Trust

The British Liver Trust provides information and support on all types of liver disease.

British Liver Trust

Dr Laura Wyness

Award winning Registered Nutritionist specialising in menopausal and evidence-based nutrition communication.

Scottish Life Sciences Association

The voice of Scotland’s Lifesciences industries


A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®